LIANBIO
LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and major Asian markets through partnerships that provide access to the best science-driven therapeutic discoveries. LianBio collaborates with world-class partners across a diverse array of therapeutic and geographic areas to build out a pipeline based on disease relevance and the ability to impact patients with transformative mechanisms and precision-based therapeutics.
LIANBIO
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2019-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.lianbio.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
310 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Apache Microsoft Exchange Online Office 365 Mail IPv6
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
CymaBay Therapeutics
CymaBay Therapeutics is focused on the development and commercialization of proprietary new medicines for critical human diseases.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
ValenzaBio
ValenzaBio is developing safe and effective treatment options for patients with autoimmune and inflammatory diseases.
Zai Lab
Zai Lab brings transformative medicines for cancer, autoimmune, and infectious diseases to patients in China and around the world.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
BlackRock
BlackRock investment in Series A - LianBio
Vida Ventures
Vida Ventures investment in Series A - LianBio
Perceptive Advisors
Perceptive Advisors investment in Series A - LianBio
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series A - LianBio
T. Rowe Price
T. Rowe Price investment in Series A - LianBio
Pfizer
Pfizer investment in Series A - LianBio
Viking Global Investors
Viking Global Investors investment in Series A - LianBio
Wellington Management
Wellington Management investment in Series A - LianBio
RA Capital Management
RA Capital Management investment in Series A - LianBio
Tybourne Capital Management
Tybourne Capital Management investment in Series A - LianBio
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-04 | LianBio Appoints Michael Humphries as Chief Scientific Advisor |
| 2021-03-18 | LianBio Announces Appointment of Yi Larson as Chief Financial Officer |
Official Site Inspections
http://www.lianbio.com Semrush global rank: 4.54 M Semrush visits lastest month: 2.32 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
